Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug
Status:
Terminated
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study will test the effectiveness of an investigational treatment for patients with
ragweed-induced asthma, sometimes called fall seasonal asthma. The treatment being tested is
a series of anti-ragweed shots. The purpose of the study is to determine whether a short
series of injections with Amb a 1-immunostimulatory oligodeoxyribonucleotide conjugate (AIC)
can cause a long-lasting reduction in the symptoms of asthma that are caused by fall hay
fever allergies.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)